UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	Effect of Lutein, Zeaxanthin supplements on human.
Title of the study (Brief title)	Lutein Zeaxanthin clinical trial
Region	Japan

Condition
Condition	Healthy people
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	Effect of Lutein, Zeaxanthin supplements on human.
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1	Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	contrast sensitivity Accommodation ability
Key secondary outcomes	Visual Analog Scale

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Cluster
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Lutein,Zeaxanthin supplements 2 capsule/day
Interventions/Control_2	Placebo supplements 2 capsule/day
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	30 years-old <=
Age-upper limit	65 years-old >=
Gender	Male and Female
Key inclusion criteria	(1) persons who will generally be judged as healthy (2) Persons who will give written informed consent by theirselves
Key exclusion criteria	(1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficay with the effect evaluated in this study (2) persons who changed their habitats of supplements whitin 4 weeks. (3) Persons who work in night shift or in day and night shift (4) persons who have been treated their illness or prevention in a clinic at their informed consent (5) persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6) persons with the medical histories of alcoholism or drug dependence (7) persons who might be developed allergic reaction to foods. (8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study preiod (9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10) persons who will not be judged suitable to the participants by the investigator.
Target sample size	40

Research contact person
Name of lead principal investigator	Kuniyoshi Shimizu
Organization	Faculty of Agriculture, Kyushu University
Division name	Laboratory of Systematic Forest and Forest Products Science
Address	6-10-1 Hakozaki, Higashi-ku, Fukuoka
TEL	092-642-3002
Email	shimizu@agr.kyushu-u.ac.jp

Public contact
Name of contact person	Kuniyoshi Shimizu
Organization	Faculty of Agriculture, Kyushu University
Division name	Laboratory of Systematic Forest and Forest Products Science
Address	6-10-1 Hakozaki, Higashi-ku, Fukuoka
TEL	092-642-3002
Homepage URL
Email	shimizu@agr.kyushu-u.ac.jp

Sponsor
Institute	Laboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University
Institute
Department

Funding Source
Organization	Stella Sasaki Co.,Ltd.
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor	Fuculuty of Humanity-Oriented Science and Eingineering, Kindai University
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2018 Year 03 Month 15 Day

Progress
Recruitment status	Completed
Date of protocol fixation	2016 Year 11 Month 28 Day
Anticipated trial start date	2017 Year 01 Month 16 Day
Last follow-up date	2017 Year 03 Month 25 Day
Date of closure to data entry	2017 Year 04 Month 07 Day
Date trial data considered complete	2017 Year 04 Month 26 Day
Date analysis concluded	2017 Year 05 Month 29 Day

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information

Management information
Registered date	2017 Year 01 Month 16 Day
Last modified on	2018 Year 07 Month 09 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029565